Veronica Galvan is a professor and the Donald W. Reynolds Endowed Chair of Aging Research in the Department of Biochemistry and Molecular Biology at the

University of Oklahoma Health Sciences Center The University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma, United States, is the health sciences branch of the University of Oklahoma. It serves as the primary place of training for many of Oklahoma's health professions. It is ...

. Since December 2022, she has served as director of the Oklahoma Nathan Shock Center on Aging. She also serves as co-director of the Center for Geroscience and Healthy Brain Aging at the University of Oklahoma Health Sciences Center. Galvan attended the Center for Advanced Studies in Exact Sciences University, Buenos Aires, Argentina, and received her Master's degree in 1994. She then moved to the

University of Chicago The University of Chicago (UChicago, Chicago, or UChi) is a Private university, private research university in Chicago, Illinois, United States. Its main campus is in the Hyde Park, Chicago, Hyde Park neighborhood on Chicago's South Side, Chic ...

where she received her Ph.D. in Virology in 1999 under the mentorship of Dr. Bernard Roizman. She then moved to the

Buck Institute for Research on Aging The Buck Institute for Research on Aging is an independent biomedical research institute that researches aging and age-related disease. The mission of the Buck Institute is to extend the healthy years of life. The Buck Institute is one of nine cen ...

where she completed postdoctoral research in Neuroscience under the mentorship of Dr. Dale Bredesen. She joined the faculty of the University of Texas Health Science Center San Antonio in 1999 as an assistant professor, and was promoted to associate professor with Tenure in 2016. In 2021 she moved to the

where she became a full professor. Galvan is a Fellow of the

American Aging Association The American Aging Association is a non-profit, tax-exempt biogerontology organization of scientists and laypeople dedicated to biomedical aging studies and geroscience, with the goal of slowing the aging process to extend the healthy human li ...

, the largest scientific society devoted to the study of the biology of aging in the United States of America, and served as its president from 2021 to 2022. Since 2021, she has served as editor in chief of the journal ''

GeroScience ''GeroScience'' (formerly ''Age''; ''Journal of the American Aging Association'') is a scientific journal focused on the biology of aging and on mechanistic studies using clinically relevant models of aging and chronic age-related diseases. The jo ...

''. Galvan's laboratory focuses on the molecular biology of

Alzheimer's disease Alzheimer's disease (AD) is a neurodegenerative disease and the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems wit ...

and other

tauopathies Tauopathies are a class of neurodegenerative diseases characterized by the aggregation of abnormal tau protein. Hyperphosphorylation of tau proteins causes them to dissociate from microtubules and form insoluble aggregates called neurofibrillary t ...

, with an emphasis on

mTOR The mammalian target of rapamycin (mTOR), also referred to as the mechanistic target of rapamycin, and sometimes called FK506-binding protein 12-rapamycin-associated protein 1 (FRAP1), is a kinase that in humans is encoded by the ''MTOR'' gene. ...

signaling and

rapamycin Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ rejection, organ transplant rejection, treat a rare lung disease called lymphang ...

References

{{DEFAULTSORT:Galvan, Veronica University of Oklahoma faculty Eastern Illinois University alumni University of Buenos Aires alumni University of Chicago alumni Year of birth missing (living people) Living people